Home > Blog > Ind success strategy building a high quality ind from scratch with strategic gap analysis

1 min read

IND Success Strategy: Building a High-Quality IND from Scratch with Strategic Gap Analysis

Clinical Trial Regulations Strategic Consulting

Learn how our regulatory affairs team was able to work with a sponsor to build a complete, FDA-compliant IND from scratch. Our collaborative efforts led to successful IND submission and initiation of clinical trials with confidence, preventing potential delays and clinical holds.

A sponsor without internal regulatory expertise needed to create and submit an Investigational New Drug (IND) application and turned to Veristat for comprehensive support. They required in-depth regulatory guidance to ensure a compliant IND submission and smooth development process moving forward, knowing that missing or incomplete documentation could cause costly delays.

👉 In this case study, learn how our regulatory team was able to work with the sponsor to solve challenges across numerous areas including:

  • Strategic gap analysis

  • IND planning and management

  • Medical writing coordination

  • Document authoring

  • eCTD publishing

  • FDA submission support

Download our complete case study "IND Success Strategy: Building a High-Quality IND from Scratch with Strategic Gap Analysis"
DOWNLOAD

2 min read

Outsourcing in Clinical Trials New England

Oct 2, 2025  Veristat Events

Meet Veristat at Outsourcing in Clinical Trials New England

Veristat is excited to participate in the 17th Annual...

1 min read

BIOSpain 2025

Sep 18, 2025  Veristat Events

Meet Veristat at BIOSpain, October 7 - 9, 2025 

Veristat is excited to attend BIOSpain 2025, one of Europe’s largest...